Tompkins Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15
| Closed | -$7.03K | – | 622 |
|
|
2024
Q2 | $7.03K | Hold |
15
| – | – | ﹤0.01% | 504 |
|
|
2024
Q1 | $6.27K | Hold |
15
| – | – | ﹤0.01% | 537 |
|
|
2023
Q4 | $6.1K | Hold |
15
| – | – | ﹤0.01% | 532 |
|
|
2023
Q3 | $5.22K | Hold |
15
| – | – | ﹤0.01% | 507 |
|
|
2023
Q2 | $5.28K | Hold |
15
| – | – | ﹤0.01% | 514 |
|
|
2023
Q1 | $4.73K | Hold |
15
| – | – | ﹤0.01% | 539 |
|
|
2022
Q4 | $4K | Buy |
+15
| New | +$4K | ﹤0.01% | 548 |
|
|
2020
Q3 | – | Sell |
-50
| Closed | -$15K | – | 398 |
|
|
2020
Q2 | $15K | Hold |
50
| – | – | ﹤0.01% | 304 |
|
|
2020
Q1 | $12K | Hold |
50
| – | – | ﹤0.01% | 314 |
|
|
2019
Q4 | $11K | Buy |
+50
| New | +$11K | ﹤0.01% | 341 |
|
|
2014
Q3 | – | Sell |
-4
| Closed | – | – | 518 |
|
|
2014
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 543 |
|
|
2014
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 546 |
|